Atara Biotherapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Atara Biotherapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • Atara Biotherapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $48.9M, a 21.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $48.9M -$13.2M -21.3% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $52M -$13.2M -20.2% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $54.9M -$13.1M -19.2% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 $59.2M -$11.7M -16.5% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $62.2M -$11.4M -15.5% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $65.1M +$46.2M +244% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $68M +$41.9M +160% Dec 31, 2022 10-K 2024-03-28
Q3 2022 $70.8M +$45.8M +183% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $73.6M +$62M +537% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $18.9M +$7M +58.7% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $26.2M +$13.9M +113% Dec 31, 2021 10-K 2023-02-08
Q3 2021 $25.1M +$13M +108% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $11.5M -$1.77M -13.3% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $11.9M -$1.76M -12.9% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $12.3M -$1.7M -12.2% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $12.1M -$2.14M -15% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $13.3M -$1.08M -7.47% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $13.7M -$350K -2.49% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $14M +$14M Dec 31, 2019 10-K 2021-03-01
Q3 2019 $14.2M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $14.4M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $14M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $0 Dec 31, 2018 10-K 2020-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.